The risk or severity of adverse effects can be increased when flurazepam is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when olanzapine is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when diazepam is combined with Flibanserin.


The risk or severity of adverse effects can be increased when nisoldipine is combined with clonidine.


The risk or severity of adverse effects can be increased when Metipranolol is combined with cilazapril.


The risk or severity of adverse effects can be increased when nisoldipine is combined with propranolol.


The risk or severity of adverse effects can be increased when tacrolimus is combined with L-phenylalanine.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when propofol is combined with amobarbital.


The risk or severity of adverse effects can be increased when Spirapril is combined with celecoxib.


The risk or severity of adverse effects can be increased when Propacetamol is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when sotalol is combined with trandolapril.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with LEVOSIMENDAN.


The risk or severity of adverse effects can be increased when Clofarabine is combined with apraclonidine.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with Difenoxin.


The risk or severity of adverse effects can be increased when metolazone is combined with acetyldigitoxin.


The risk or severity of adverse effects can be increased when Vildagliptin is combined with fosinopril.


The risk or severity of adverse effects can be increased when chlormezanone is combined with tiagabine.


The risk or severity of adverse effects can be increased when chlormezanone is combined with zonisamide.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when metoclopramide is combined with reserpine.


The risk or severity of adverse effects can be increased when Masoprocol is combined with leflunomide.


The risk or severity of adverse effects can be increased when phenytoin is combined with clidinium.


The risk or severity of adverse effects can be increased when Fospropofol is combined with butalbital.


The risk or severity of adverse effects can be increased when zaleplon is combined with bromazepam.


The risk or severity of adverse effects can be increased when lisinopril is combined with mycophenolate mofetil.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with domperidone.


The risk or severity of adverse effects can be increased when butamben is combined with METAXALONE.


The risk or severity of adverse effects can be increased when Spirapril is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when bromazepam is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when pramipexole is combined with labetalol.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when pramipexole is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when thiamylal is combined with maprotiline.


The risk or severity of adverse effects can be increased when azelastine is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when pramipexole is combined with doxazosin.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with carvedilol.


The risk or severity of adverse effects can be increased when trazodone is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with flunisolide.


The risk or severity of adverse effects can be increased when Butethal is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when HEROIN is combined with ethosuximide.


The risk or severity of adverse effects can be increased when loratadine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when oxymorphone is combined with etizolam.


The risk or severity of adverse effects can be increased when HEROIN is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with chlormezanone.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with Escitalopram.


The risk or severity of adverse effects can be increased when fluoxetine is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when Apixaban is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when bromocriptine is combined with antipyrine.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with Levomepromazine.


The risk or severity of adverse effects can be increased when niflumic acid is combined with halcinonide.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with flurazepam.


The risk or severity of adverse effects can be increased when procarbazine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when niflumic acid is combined with difluprednate.


The risk or severity of adverse effects can be increased when indomethacin is combined with chloroquine.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Dothiepin is combined with dobutamine.


The risk or severity of adverse effects can be increased when cabergoline is combined with thiopental.


The risk or severity of adverse effects can be increased when leflunomide is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when benztropine is combined with tubocurarine.


The risk or severity of adverse effects can be increased when tiapride is combined with levodopa.


The risk or severity of adverse effects can be increased when leflunomide is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when azelastine is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with Tapentadol.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Pramocaine.


The risk or severity of adverse effects can be increased when hexetidine is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when leflunomide is combined with Droxicam.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with flunarizine.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when carprofen is combined with haloperidol.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when mecamylamine is combined with Eplerenone.


The risk or severity of adverse effects can be increased when butalbital is combined with carisoprodol.


The risk or severity of adverse effects can be increased when risperidone is combined with oxazepam.


The risk or severity of adverse effects can be increased when Nabilone is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with resveratrol.


The risk or severity of adverse effects can be increased when methysergide is combined with isoniazid.


The risk or severity of adverse effects can be increased when Nabilone is combined with Metipranolol.


The risk or severity of adverse effects can be increased when indapamide is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when secobarbital is combined with Iloperidone.


The risk or severity of adverse effects can be increased when metoclopramide is combined with desipramine.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with topiramate.


The risk or severity of adverse effects can be increased when Efonidipine is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when trandolapril is combined with Apremilast.


The risk or severity of adverse effects can be increased when Miltefosine is combined with gabapentin.


The risk or severity of adverse effects can be increased when Lofexidine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when Levetiracetam is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when MAGNESIUM SULFATE is combined with venlafaxine.


The risk or severity of adverse effects can be increased when DEFLAZACORT is combined with NICORANDIL.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with Desloratadine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with meclizine.


The risk or severity of adverse effects can be increased when nicardipine is combined with nadolol.


The risk or severity of adverse effects can be increased when docetaxel is combined with thioguanine.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with Lorcaserin.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when docetaxel is combined with MEGESTROL ACETATE.


The risk or severity of adverse effects can be increased when docetaxel is combined with aminoglutethimide.


The risk or severity of adverse effects can be increased when docetaxel is combined with LYCOPENE.


The risk or severity of adverse effects can be increased when propoxyphene is combined with trimipramine.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with nifedipine.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with etizolam.


The risk or severity of adverse effects can be increased when Spirapril is combined with Propacetamol.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with papaverine.


The risk or severity of adverse effects can be increased when labetalol is combined with Metipranolol.


The risk or severity of adverse effects can be increased when zonisamide is combined with Ramelteon.


The risk or severity of adverse effects can be increased when isoproterenol is combined with PSEUDOEPHEDRINE.


The risk or severity of adverse effects can be increased when azelastine is combined with Propacetamol.


The risk or severity of adverse effects can be increased when fenbufen is combined with loteprednol.


The risk or severity of adverse effects can be increased when captopril is combined with carprofen.


The risk or severity of adverse effects can be increased when procarbazine is combined with isoetharine.


The risk or severity of adverse effects can be increased when Etomidate is combined with proparacaine.


The risk or severity of adverse effects can be increased when isoflurane is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when Butethal is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Retigabine.


The risk or severity of adverse effects can be increased when triprolidine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when fludiazepam is combined with dantrolene.


The risk or severity of adverse effects can be increased when isoflurane is combined with gabapentin.


The risk or severity of adverse effects can be increased when lisinopril is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when Paliperidone is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when Pipotiazine is combined with methylphenidate.


The risk or severity of adverse effects can be increased when Paliperidone is combined with Remoxipride.


The risk or severity of adverse effects can be increased when betamethasone is combined with atorvastatin.


The risk or severity of adverse effects can be increased when propofol is combined with thiamylal.


The risk or severity of adverse effects can be increased when Etomidate is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when olanzapine is combined with pentazocine.


The risk or severity of adverse effects can be increased when Vilazodone is combined with Phenelzine.


The risk or severity of adverse effects can be increased when promazine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with Iloperidone.


The risk or severity of adverse effects can be increased when pergolide is combined with sulfanilamide.


The risk or severity of adverse effects can be increased when propofol is combined with halothane.


The risk or severity of adverse effects can be increased when propofol is combined with Bretylium.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with MELPERONE.


The risk or severity of adverse effects can be increased when Bortezomib is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when propranolol is combined with cilazapril.


The risk or severity of adverse effects can be increased when fosinopril is combined with indomethacin.


The risk or severity of adverse effects can be increased when medrysone is combined with Pefloxacin.


The risk or severity of adverse effects can be increased when zaleplon is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when fludrocortisone is combined with enoxacin.


The risk or severity of adverse effects can be increased when leflunomide is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with oxaprozin.


The risk or severity of adverse effects can be increased when apomorphine is combined with losartan.


The risk or severity of adverse effects can be increased when nimesulide is combined with Pitavastatin.


The risk or severity of adverse effects can be increased when Asenapine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when flurazepam is combined with sevoflurane.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when tizanidine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when ethopropazine is combined with TRIMETHAPHAN.


The risk or severity of adverse effects can be increased when aspirin is combined with triamcinolone.


The risk or severity of adverse effects can be increased when formestane is combined with galanthamine.


The risk or severity of adverse effects can be increased when formestane is combined with Isoflurophate.


The risk or severity of adverse effects can be increased when Fospropofol is combined with clidinium.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with hydralazine.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when Normethadone is combined with meclizine.


The risk or severity of adverse effects can be increased when prilocaine is combined with Butethal.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with bumetanide.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Perospirone.


The risk or severity of adverse effects can be increased when Butoconazole is combined with Pitavastatin.


The risk or severity of adverse effects can be increased when suprofen is combined with niflumic acid.


The risk or severity of adverse effects can be increased when nystatin is combined with Lacidipine.


The risk or severity of adverse effects can be increased when ramipril is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when doxepin is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when doxepin is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when trazodone is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Fospropofol.


The risk or severity of adverse effects can be increased when pentazocine is combined with diphenhydramine.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with Fospropofol.


The risk or severity of adverse effects can be increased when mepivacaine is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when azelastine is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when azelastine is combined with niflumic acid.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when tropicamide is combined with Tramadol.


The risk or severity of adverse effects can be increased when apomorphine is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with bumetanide.


The risk or severity of adverse effects can be increased when pentamidine is combined with nimesulide.


The risk or severity of adverse effects can be increased when azelastine is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when Eletriptan is combined with mesoridazine.


The risk or severity of adverse effects can be increased when Eletriptan is combined with maprotiline.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when Torasemide is combined with triamterene.


The risk or severity of adverse effects can be increased when secobarbital is combined with Halazepam.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Melatonin is combined with zonisamide.


The risk or severity of adverse effects can be increased when hydromorphone is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with fexofenadine.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with tetracaine.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Zucapsaicin.


The risk or severity of adverse effects can be increased when Tramadol is combined with Normethadone.


The risk or severity of adverse effects can be increased when propofol is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when oxycodone is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when Halobetasol is combined with malathion.


The risk or severity of adverse effects can be increased when tolterodine is combined with nalbuphine.


The risk or severity of adverse effects can be increased when pentazocine is combined with PAMABROM.


The risk or severity of adverse effects can be increased when methysergide is combined with bicalutamide.


The risk or severity of adverse effects can be increased when etoposide is combined with atorvastatin.


The risk or severity of adverse effects can be increased when norepinephrine is combined with PSEUDOEPHEDRINE.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with trichlormethiazide.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with felodipine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with irbesartan.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when propofol is combined with zopiclone.


The risk or severity of adverse effects can be increased when prilocaine is combined with topiramate.


The risk or severity of adverse effects can be increased when dobutamine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when Naftifine is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when Anidulafungin is combined with nimodipine.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when methysergide is combined with rabeprazole.


The risk or severity of adverse effects can be increased when vigabatrin is combined with venlafaxine.


The risk or severity of adverse effects can be increased when butabarbital is combined with Difenoxin.


The risk or severity of adverse effects can be increased when Pipamperone is combined with penbutolol.


The risk or severity of adverse effects can be increased when chloroquine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when oxazepam is combined with citalopram.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with Carbamylcholine.


The risk or severity of adverse effects can be increased when fosinopril is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when glutethimide is combined with ethotoin.


The risk or severity of adverse effects can be increased when betaxolol is combined with minoxidil.


The risk or severity of adverse effects can be increased when dyclonine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with protriptyline.


The risk or severity of adverse effects can be increased when CICLOPIROX is combined with nilvadipine.


The risk or severity of adverse effects can be increased when amitriptyline is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with MELPERONE.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with nadolol.


The risk or severity of adverse effects can be increased when zotepine is combined with trimipramine.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with felbamate.


The risk or severity of adverse effects can be increased when epinephrine is combined with tetrahydrozoline.


The risk or severity of adverse effects can be increased when enflurane is combined with etizolam.


The risk or severity of adverse effects can be increased when risperidone is combined with Flibanserin.


The risk or severity of adverse effects can be increased when bupivacaine is combined with fenoldopam.


The risk or severity of adverse effects can be increased when oxazepam is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when clotrimazole is combined with cinnarizine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when isoflurane is combined with chlormezanone.


The risk or severity of adverse effects can be increased when azelastine is combined with salicylamide.


The risk or severity of adverse effects can be increased when codeine is combined with nitrazepam.


The risk or severity of adverse effects can be increased when Flupentixol is combined with clonazepam.


The risk or severity of adverse effects can be increased when ketoprofen is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Iloperidone.


The risk or severity of adverse effects can be increased when Halazepam is combined with paroxetine.


The risk or severity of adverse effects can be increased when Asenapine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when butabarbital is combined with Melatonin.


The risk or severity of adverse effects can be increased when dicyclomine is combined with Trospium.


The risk or severity of adverse effects can be increased when clomipramine is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when morphine is combined with Sacubitril.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with trazodone.


The risk or severity of adverse effects can be increased when ropinirole is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with ketamine.


The risk or severity of adverse effects can be increased when oxiconazole is combined with flunarizine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with enflurane.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with Flibanserin.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when argatroban is combined with Nintedanib.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when fosinopril is combined with furosemide.


The risk or severity of adverse effects can be increased when LISURIDE is combined with metronidazole.


The risk or severity of adverse effects can be increased when diflunisal is combined with antipyrine.


The risk or severity of adverse effects can be increased when morniflumate is combined with indomethacin.


The risk or severity of adverse effects can be increased when indapamide is combined with cilazapril.


The risk or severity of adverse effects can be increased when butabarbital is combined with thioridazine.


The risk or severity of adverse effects can be increased when clomipramine is combined with prazosin.


The risk or severity of adverse effects can be increased when Bevantolol is combined with acetylcholine.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with Remoxipride.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with indomethacin.


The risk or severity of adverse effects can be increased when phenobarbital is combined with Pramocaine.


The risk or severity of adverse effects can be increased when amitriptyline is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with Articaine.


The risk or severity of adverse effects can be increased when Remoxipride is combined with Difenoxin.


The risk or severity of adverse effects can be increased when clozapine is combined with cetirizine.


The risk or severity of adverse effects can be increased when propofol is combined with fosinopril.


The risk or severity of adverse effects can be increased when selegiline is combined with Arformoterol.


The risk or severity of adverse effects can be increased when Salsalate is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when tolnaftate is combined with diltiazem.


The risk or severity of adverse effects can be increased when bumetanide is combined with terazosin.


The risk or severity of adverse effects can be increased when cilazapril is combined with ketoprofen.


The risk or severity of adverse effects can be increased when temazepam is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Perospirone.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when floctafenine is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when nitrazepam is combined with amoxapine.


The risk or severity of adverse effects can be increased when nitrazepam is combined with nortriptyline.


The risk or severity of adverse effects can be increased when alprazolam is combined with Butethal.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with oxprenolol.


The risk or severity of adverse effects can be increased when Flupentixol is combined with Melatonin.


The risk or severity of adverse effects can be increased when Tedizolid phosphate is combined with triflupromazine.


The risk or severity of adverse effects can be increased when floctafenine is combined with acemetacin.


The risk or severity of adverse effects can be increased when Isoconazole is combined with Pitavastatin.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with prazepam.


The risk or severity of adverse effects can be increased when Tedizolid phosphate is combined with haloperidol.


The risk or severity of adverse effects can be increased when alprazolam is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when alprazolam is combined with lithium ion.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when captopril is combined with resveratrol.


The risk or severity of adverse effects can be increased when tioconazole is combined with gabapentin.


The risk or severity of adverse effects can be increased when prazosin is combined with Clevidipine.


The risk or severity of adverse effects can be increased when pentobarbital is combined with chlormezanone.


The risk or severity of adverse effects can be increased when mesoridazine is combined with scopolamine.


The risk or severity of adverse effects can be increased when meprobamate is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when pentazocine is combined with Retigabine.


The risk or severity of adverse effects can be increased when pentobarbital is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when buspirone is combined with triflupromazine.


The risk or severity of adverse effects can be increased when Fesoterodine is combined with hydromorphone.


The risk or severity of adverse effects can be increased when Tramadol is combined with Torasemide.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with diclofenac.


The risk or severity of adverse effects can be increased when Halobetasol is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with enalapril.


The risk or severity of adverse effects can be increased when risperidone is combined with fexofenadine.


The risk or severity of adverse effects can be increased when CICLOPIROX is combined with nisoldipine.


The risk or severity of adverse effects can be increased when venlafaxine is combined with warfarin.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with clidinium.


The risk or severity of adverse effects can be increased when triazolam is combined with duloxetine.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when estazolam is combined with sulpiride.


The risk or severity of adverse effects can be increased when tioconazole is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when MOXONIDINE is combined with propofol.


The risk or severity of adverse effects can be increased when estazolam is combined with carisoprodol.


The risk or severity of adverse effects can be increased when ritodrine is combined with MEPHENTERMINE.


The risk or severity of adverse effects can be increased when Tapentadol is combined with metoclopramide.


The risk or severity of adverse effects can be increased when triazolam is combined with fluoxetine.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with amoxapine.


The risk or severity of adverse effects can be increased when alclofenac is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when nifedipine is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when sulconazole is combined with lovastatin.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with procarbazine.


The risk or severity of adverse effects can be increased when Tapentadol is combined with AMPHETAMINE.


The risk or severity of adverse effects can be increased when tropicamide is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with tamoxifen.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Delavirdine.


The risk or severity of adverse effects can be increased when ethopropazine is combined with Trospium.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Normethadone.


The risk or severity of adverse effects can be increased when amitriptyline is combined with Salmeterol.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with haloperidol.


The risk or severity of adverse effects can be increased when Fluprednidene is combined with Echothiophate.


The risk or severity of adverse effects can be increased when nimodipine is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with oxycodone.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with oxymorphone.


The risk or severity of adverse effects can be increased when amisulpride is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with Melatonin.


The risk or severity of adverse effects can be increased when Levetiracetam is combined with Iloperidone.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with Olmesartan.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with clonazepam.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with paramethasone.


The risk or severity of adverse effects can be increased when estazolam is combined with propoxyphene.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when diazepam is combined with meclizine.


The risk or severity of adverse effects can be increased when Sacubitril is combined with terazosin.


The risk or severity of adverse effects can be increased when dibucaine is combined with proparacaine.


The risk or severity of adverse effects can be increased when Salsalate is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when propofol is combined with trimipramine.


The risk or severity of adverse effects can be increased when propofol is combined with procaine.


The risk or severity of adverse effects can be increased when Olsalazine is combined with betamethasone.


The risk or severity of adverse effects can be increased when dibucaine is combined with Halazepam.


The risk or severity of adverse effects can be increased when Salsalate is combined with prednisone.


The risk or severity of adverse effects can be increased when diazepam is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when alprazolam is combined with estazolam.


The risk or severity of adverse effects can be increased when Carbetocin is combined with nadolol.


The risk or severity of adverse effects can be increased when diazepam is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with fexofenadine.


The risk or severity of adverse effects can be increased when amitriptyline is combined with rasagiline.


The risk or severity of adverse effects can be increased when propofol is combined with HEROIN.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Halazepam.


The risk or severity of adverse effects can be increased when nalbuphine is combined with amobarbital.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with phenytoin.


The risk or severity of adverse effects can be increased when pentazocine is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with proparacaine.


The risk or severity of adverse effects can be increased when nitric oxide is combined with cilazapril.


The risk or severity of adverse effects can be increased when biperiden is combined with Vecuronium.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with indapamide.


The risk or severity of adverse effects can be increased when Tolcapone is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when D-mannitol is combined with Bretylium.


The risk or severity of adverse effects can be increased when Tolcapone is combined with furazolidone.


The risk or severity of adverse effects can be increased when nicergoline is combined with Telaprevir.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when ramipril is combined with nabumetone.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Flupentixol.


The risk or severity of adverse effects can be increased when perphenazine is combined with prilocaine.


The risk or severity of adverse effects can be increased when triamcinolone is combined with pyridostigmine.


The risk or severity of adverse effects can be increased when perphenazine is combined with ethotoin.


The risk or severity of adverse effects can be increased when clomipramine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when Perospirone is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when clonazepam is combined with clozapine.


The risk or severity of adverse effects can be increased when methyldopa is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when pentobarbital is combined with FLUPHENAZINE.


The risk or severity of adverse effects can be increased when pirenzepine is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when enflurane is combined with prazepam.


The risk or severity of adverse effects can be increased when oxazepam is combined with zonisamide.


The risk or severity of adverse effects can be increased when gabapentin is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when enflurane is combined with oxprenolol.


The risk or severity of adverse effects can be increased when captopril is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when diltiazem is combined with terazosin.


The risk or severity of adverse effects can be increased when Olopatadine is combined with salicylic acid.


The risk or severity of adverse effects can be increased when CICLOPIROX is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when barnidipine is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when Olopatadine is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with METAXALONE.


The risk or severity of adverse effects can be increased when ketorolac is combined with mefenamic acid.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when tretinoin is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when salicylic acid is combined with ibuprofen.


The risk or severity of adverse effects can be increased when cocaine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when ipratropium is combined with ANISOTROPINE METHYLBROMIDE.


The risk or severity of adverse effects can be increased when halothane is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when halothane is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when halothane is combined with nitric oxide.


The risk or severity of adverse effects can be increased when xylometazoline is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when Fospropofol is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when phenobarbital is combined with Desloratadine.


The risk or severity of adverse effects can be increased when Tavaborole is combined with PERHEXILINE.


The risk or severity of adverse effects can be increased when Aclidinium is combined with levorphanol.


The risk or severity of adverse effects can be increased when phenobarbital is combined with mepivacaine.


The risk or severity of adverse effects can be increased when pentoxifylline is combined with Apixaban.


The risk or severity of adverse effects can be increased when quinapril is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when furazolidone is combined with lithium ion.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when celecoxib is combined with ketoprofen.


The risk or severity of adverse effects can be increased when prazepam is combined with trimipramine.


The risk or severity of adverse effects can be increased when spiramycin is combined with pravastatin.


The risk or severity of adverse effects can be increased when Bivalirudin is combined with Nintedanib.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with flunisolide.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when levorphanol is combined with nitrazepam.


The risk or severity of adverse effects can be increased when enflurane is combined with baclofen.


The risk or severity of adverse effects can be increased when indomethacin is combined with antipyrine.


The risk or severity of adverse effects can be increased when Torasemide is combined with nisoldipine.


The risk or severity of adverse effects can be increased when fenoprofen is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when miconazole is combined with cinnarizine.


The risk or severity of adverse effects can be increased when estrone is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when phenylpropanolamine is combined with metaraminol.


The risk or severity of adverse effects can be increased when Rufinamide is combined with clozapine.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with sulfapyridine.


The risk or severity of adverse effects can be increased when Perospirone is combined with Iloperidone.


The risk or severity of adverse effects can be increased when celecoxib is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when tacrolimus is combined with floxuridine.


The risk or severity of adverse effects can be increased when lorazepam is combined with lidocaine.


The risk or severity of adverse effects can be increased when flurandrenolide is combined with galanthamine.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when Carbetocin is combined with Rotigotine.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with Propiverine.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when zopiclone is combined with sertraline.


The risk or severity of adverse effects can be increased when nimesulide is combined with atorvastatin.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when cabergoline is combined with lithium ion.


The risk or severity of adverse effects can be increased when ketorolac is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when felbamate is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when hydralazine is combined with Riociguat.


The risk or severity of adverse effects can be increased when Tramadol is combined with chlordiazepoxide.


The risk or severity of adverse effects can be increased when Aclidinium is combined with topiramate.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with halcinonide.


The risk or severity of adverse effects can be increased when clorazepate is combined with benzocaine.


The risk or severity of adverse effects can be increased when nortriptyline is combined with sumatriptan.


The risk or severity of adverse effects can be increased when clorazepate is combined with vigabatrin.


The risk or severity of adverse effects can be increased when clorazepate is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with difluprednate.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with Olopatadine.


The risk or severity of adverse effects can be increased when triflupromazine is combined with felbamate.


The risk or severity of adverse effects can be increased when levodopa is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when reserpine is combined with zotepine.


The risk or severity of adverse effects can be increased when Trospium is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when meprobamate is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when baclofen is combined with imipramine.


The risk or severity of adverse effects can be increased when clorazepate is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when methadone is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when methylprednisolone is combined with memantine.


The risk or severity of adverse effects can be increased when epirizole is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when Tramadol is combined with METHOHEXITAL.


The risk or severity of adverse effects can be increased when Rufinamide is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when methylprednisolone is combined with Gatifloxacin.


The risk or severity of adverse effects can be increased when Etidocaine is combined with desipramine.


The risk or severity of adverse effects can be increased when thiamylal is combined with Pipamperone.


The risk or severity of adverse effects can be increased when metoprolol is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when NATAMYCIN is combined with flunarizine.


The risk or severity of adverse effects can be increased when clozapine is combined with Halazepam.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with niflumic acid.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when clozapine is combined with proparacaine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when ramipril is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when celecoxib is combined with mecamylamine.


The risk or severity of adverse effects can be increased when EFINACONAZOLE is combined with Lacidipine.


The risk or severity of adverse effects can be increased when tolmetin is combined with aspirin.


The risk or severity of adverse effects can be increased when Olopatadine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when Naftifine is combined with acemetacin.


The risk or severity of adverse effects can be increased when morphine is combined with dyclonine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when morphine is combined with propoxyphene.


The risk or severity of adverse effects can be increased when EFINACONAZOLE is combined with Azelnidipine.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with benzocaine.


The risk or severity of adverse effects can be increased when methadone is combined with topiramate.


The risk or severity of adverse effects can be increased when rizatriptan is combined with procarbazine.


The risk or severity of adverse effects can be increased when cabergoline is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when Articaine is combined with desipramine.


The risk or severity of adverse effects can be increased when Carbetocin is combined with Sacubitril.


The risk or severity of adverse effects can be increased when cabergoline is combined with tetracycline.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with pimozide.


The risk or severity of adverse effects can be increased when cetirizine is combined with meclizine.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Pirlindole.


The risk or severity of adverse effects can be increased when enalapril is combined with D-mannitol.


The risk or severity of adverse effects can be increased when clorazepate is combined with flurazepam.


The risk or severity of adverse effects can be increased when trichlormethiazide is combined with digitoxin.


The risk or severity of adverse effects can be increased when enalapril is combined with etodolac.


The risk or severity of adverse effects can be increased when butabarbital is combined with Paliperidone.


The risk or severity of adverse effects can be increased when propofol is combined with butamben.


The risk or severity of adverse effects can be increased when pimozide is combined with carisoprodol.


The risk or severity of adverse effects can be increased when amobarbital is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when benzocaine is combined with chlormezanone.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with perphenazine.


The risk or severity of adverse effects can be increased when benzocaine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with levorphanol.


The risk or severity of adverse effects can be increased when dobutamine is combined with benzphetamine.


The risk or severity of adverse effects can be increased when dobutamine is combined with ritodrine.


The risk or severity of adverse effects can be increased when nitrazepam is combined with vigabatrin.


The risk or severity of adverse effects can be increased when linezolid is combined with ERGOTAMINE.


The risk or severity of adverse effects can be increased when nitrazepam is combined with benzocaine.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with nitrazepam.


The risk or severity of adverse effects can be increased when CLOCORTOLONE is combined with NICORANDIL.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with Fesoterodine.


The risk or severity of adverse effects can be increased when nisoldipine is combined with carvedilol.


The risk or severity of adverse effects can be increased when Efonidipine is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when metoprolol is combined with furosemide.


The risk or severity of adverse effects can be increased when propantheline is combined with Propiverine.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with prednisone.


The risk or severity of adverse effects can be increased when nitroglycerin is combined with nifedipine.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when brotizolam is combined with paroxetine.


The risk or severity of adverse effects can be increased when clonazepam is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with baclofen.


The risk or severity of adverse effects can be increased when clonazepam is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when Fospropofol is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when meprobamate is combined with carisoprodol.


The risk or severity of adverse effects can be increased when quazepam is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when meprobamate is combined with sulpiride.


The risk or severity of adverse effects can be increased when Apremilast is combined with epirizole.


The risk or severity of adverse effects can be increased when quazepam is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when Conivaptan is combined with betaxolol.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with desipramine.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when Butylscopolamine is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when mirtazapine is combined with phenylpropanolamine.


The risk or severity of adverse effects can be increased when ISOSORBIDE DINITRATE is combined with Clevidipine.


The risk or severity of adverse effects can be increased when reserpine is combined with clonazepam.


The risk or severity of adverse effects can be increased when reserpine is combined with promethazine.


The risk or severity of adverse effects can be increased when methadone is combined with oxprenolol.


The risk or severity of adverse effects can be increased when epirizole is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when Ibrutinib is combined with Dabigatran etexilate.


The risk or severity of adverse effects can be increased when sevoflurane is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when codeine is combined with polythiazide.


The risk or severity of adverse effects can be increased when Tramadol is combined with prochlorperazine.


The risk or severity of adverse effects can be increased when thalidomide is combined with papaverine.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with MELPERONE.


The risk or severity of adverse effects can be increased when thalidomide is combined with nifedipine.


The risk or severity of adverse effects can be increased when zopiclone is combined with enflurane.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with topiramate.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with doxazosin.


The risk or severity of adverse effects can be increased when buspirone is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Flupentixol is combined with mesoridazine.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with labetalol.


The risk or severity of adverse effects can be increased when Tolcapone is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with sulpiride.


The risk or severity of adverse effects can be increased when methadone is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when PIPECURONIUM is combined with codeine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with progesterone.


The risk or severity of adverse effects can be increased when Conivaptan is combined with Bretylium.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with Sorafenib.


The risk or severity of adverse effects can be increased when buspirone is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when methadone is combined with baclofen.


The risk or severity of adverse effects can be increased when amitriptyline is combined with Retigabine.


The risk or severity of adverse effects can be increased when Bretylium is combined with captopril.


The risk or severity of adverse effects can be increased when ambenonium is combined with methacholine.


The risk or severity of adverse effects can be increased when secobarbital is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when Droxicam is combined with formestane.


The risk or severity of adverse effects can be increased when Droxicam is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when Naftifine is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when Naftifine is combined with flumethasone.


The risk or severity of adverse effects can be increased when Pramocaine is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when trichlormethiazide is combined with acetyldigitoxin.


The risk or severity of adverse effects can be increased when DEFLAZACORT is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Remoxipride is combined with tiagabine.


The risk or severity of adverse effects can be increased when Remoxipride is combined with ondansetron.


The risk or severity of adverse effects can be increased when cilnidipine is combined with clozapine.


The risk or severity of adverse effects can be increased when tibolone is combined with Ospemifene.


The risk or severity of adverse effects can be increased when Remoxipride is combined with zonisamide.


The risk or severity of adverse effects can be increased when perphenazine is combined with zopiclone.


The risk or severity of adverse effects can be increased when Sertaconazole is combined with nisoldipine.


The risk or severity of adverse effects can be increased when oxprenolol is combined with scopolamine.


The risk or severity of adverse effects can be increased when Fospropofol is combined with clonidine.


The risk or severity of adverse effects can be increased when oxprenolol is combined with D-mannitol.


The risk or severity of adverse effects can be increased when nimesulide is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when haloperidol is combined with Pizotifen.


The risk or severity of adverse effects can be increased when Atracurium besylate is combined with Desloratadine.


The risk or severity of adverse effects can be increased when flurazepam is combined with Perospirone.


The risk or severity of adverse effects can be increased when fexofenadine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when methylphenidate is combined with doxepin.


The risk or severity of adverse effects can be increased when lidocaine is combined with felbamate.


The risk or severity of adverse effects can be increased when leflunomide is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when diazepam is combined with duloxetine.


The risk or severity of adverse effects can be increased when Lurasidone is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when chlormezanone is combined with glutethimide.


The risk or severity of adverse effects can be increased when Olopatadine is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when chlormezanone is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when trazodone is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when butorphanol is combined with Phenelzine.


The risk or severity of adverse effects can be increased when trazodone is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Phenelzine is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when clemastine is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when morphine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when bromocriptine is combined with clofazimine.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with quinidine.


The risk or severity of adverse effects can be increased when oxiconazole is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when Olmesartan is combined with Masoprocol.


The risk or severity of adverse effects can be increased when Olmesartan is combined with ramipril.


The risk or severity of adverse effects can be increased when topiramate is combined with Retigabine.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with maprotiline.


The risk or severity of adverse effects can be increased when amphotericin b is combined with Carbetocin.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when methadone is combined with Articaine.


The risk or severity of adverse effects can be increased when docetaxel is combined with colchicine.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with mesoridazine.


The risk or severity of adverse effects can be increased when reserpine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when methadone is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when methadone is combined with metolazone.


The risk or severity of adverse effects can be increased when methadone is combined with dibucaine.


The risk or severity of adverse effects can be increased when methysergide is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when oxiconazole is combined with Amrinone.


The risk or severity of adverse effects can be increased when methysergide is combined with modafinil.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with alclometasone.


The risk or severity of adverse effects can be increased when ATROPINE is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when butorphanol is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when butorphanol is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Fludarabine.


The risk or severity of adverse effects can be increased when MAGNESIUM SULFATE is combined with paroxetine.


The risk or severity of adverse effects can be increased when lorazepam is combined with reserpine.


The risk or severity of adverse effects can be increased when aspirin is combined with desoximetasone.


The risk or severity of adverse effects can be increased when chlortetracycline is combined with Isotretinoin.


The risk or severity of adverse effects can be increased when Clevidipine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Topiroxostat is combined with atorvastatin.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when thalidomide is combined with nimodipine.


The risk or severity of adverse effects can be increased when Lofexidine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when thalidomide is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with metoclopramide.


The risk or severity of adverse effects can be increased when pimozide is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when nitrendipine is combined with MAGNESIUM OXIDE.


The risk or severity of adverse effects can be increased when dibucaine is combined with propoxyphene.


The risk or severity of adverse effects can be increased when bupivacaine is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when thiamylal is combined with ethotoin.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with Difenoxin.


The risk or severity of adverse effects can be increased when Pipamperone is combined with butalbital.


The risk or severity of adverse effects can be increased when Paliperidone is combined with chlormezanone.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with amitriptyline.


The risk or severity of adverse effects can be increased when methocarbamol is combined with Desloratadine.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Nitroprusside.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when metoprolol is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when Pipamperone is combined with captopril.


The risk or severity of adverse effects can be increased when metoprolol is combined with lisinopril.


The risk or severity of adverse effects can be increased when Pipamperone is combined with acebutolol.


The risk or severity of adverse effects can be increased when nabumetone is combined with tenoxicam.


The risk or severity of adverse effects can be increased when Glycopyrronium is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when CORTISONE ACETATE is combined with donepezil.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with Apremilast.


The risk or severity of adverse effects can be increased when promethazine is combined with procarbazine.


The risk or severity of adverse effects can be increased when loteprednol is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when Lurasidone is combined with prilocaine.


The risk or severity of adverse effects can be increased when Lurasidone is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when Lurasidone is combined with ethotoin.


The risk or severity of adverse effects can be increased when losartan is combined with D-mannitol.


The risk or severity of adverse effects can be increased when meprobamate is combined with proparacaine.


The risk or severity of adverse effects can be increased when meprobamate is combined with Halazepam.


The risk or severity of adverse effects can be increased when meprobamate is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with Olopatadine.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when nimesulide is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with procarbazine.


The risk or severity of adverse effects can be increased when proparacaine is combined with chlormezanone.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when hydrocortisone is combined with ROSOXACIN.


The risk or severity of adverse effects can be increased when Vecuronium is combined with Normethadone.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with Droxicam.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when minoxidil is combined with prazosin.


The risk or severity of adverse effects can be increased when imipramine is combined with Lacidipine.


The risk or severity of adverse effects can be increased when nitrazepam is combined with tetracaine.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when Carbetocin is combined with Aliskiren.


The risk or severity of adverse effects can be increased when trimipramine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with clonidine.


The risk or severity of adverse effects can be increased when Bretylium is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when promethazine is combined with Lorcaserin.


The risk or severity of adverse effects can be increased when Paliperidone is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when zotepine is combined with phenytoin.


The risk or severity of adverse effects can be increased when tenoxicam is combined with Tixocortol.


The risk or severity of adverse effects can be increased when Articaine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when nimodipine is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when Melatonin is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when nicardipine is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when etizolam is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when nicardipine is combined with Metipranolol.


The risk or severity of adverse effects can be increased when Tedizolid phosphate is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when fludiazepam is combined with flunarizine.


The risk or severity of adverse effects can be increased when fludiazepam is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when brimonidine is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when Ramelteon is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when sulindac is combined with antipyrine.


The risk or severity of adverse effects can be increased when etizolam is combined with Olopatadine.


The risk or severity of adverse effects can be increased when Tedizolid phosphate is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when Posaconazole is combined with bepridil.


The risk or severity of adverse effects can be increased when rescinnamine is combined with niflumic acid.


The risk or severity of adverse effects can be increased when procarbazine is combined with amisulpride.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with OLODATEROL.


The risk or severity of adverse effects can be increased when pentazocine is combined with Naloxegol.


The risk or severity of adverse effects can be increased when Posaconazole is combined with Pinaverium.


The risk or severity of adverse effects can be increased when antipyrine is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with Mometasone.


The risk or severity of adverse effects can be increased when Paliperidone is combined with enflurane.


The risk or severity of adverse effects can be increased when Etomidate is combined with citalopram.


The risk or severity of adverse effects can be increased when flurazepam is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with loteprednol.


The risk or severity of adverse effects can be increased when docetaxel is combined with Gallium nitrate.


The risk or severity of adverse effects can be increased when Olopatadine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with baclofen.


The risk or severity of adverse effects can be increased when Pirlindole is combined with isoproterenol.


The risk or severity of adverse effects can be increased when olanzapine is combined with efavirenz.


The risk or severity of adverse effects can be increased when ISOSORBIDE DINITRATE is combined with captopril.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with meclizine.


The risk or severity of adverse effects can be increased when imipramine is combined with amoxapine.


The risk or severity of adverse effects can be increased when ISOSORBIDE DINITRATE is combined with acebutolol.


The risk or severity of adverse effects can be increased when alprazolam is combined with butamben.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with butamben.


The risk or severity of adverse effects can be increased when mepivacaine is combined with etizolam.


The risk or severity of adverse effects can be increased when alclometasone is combined with mefloquine.


The risk or severity of adverse effects can be increased when zotepine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when Isavuconazole is combined with pravastatin.


The risk or severity of adverse effects can be increased when nimodipine is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when Pomalidomide is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when estrone is combined with Pefloxacin.


The risk or severity of adverse effects can be increased when pancuronium is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when estrone is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with Perospirone.


The risk or severity of adverse effects can be increased when cilazapril is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when pramipexole is combined with methyldopa.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with Cariprazine.


The risk or severity of adverse effects can be increased when betaxolol is combined with benazepril.


The risk or severity of adverse effects can be increased when pramipexole is combined with apraclonidine.


The risk or severity of adverse effects can be increased when pramipexole is combined with Telmisartan.


The risk or severity of adverse effects can be increased when oxazepam is combined with Agomelatine.


The risk or severity of adverse effects can be increased when cilazapril is combined with Naftifine.


The risk or severity of adverse effects can be increased when prazepam is combined with Pipamperone.


The risk or severity of adverse effects can be increased when reserpine is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when amifostine is combined with nitric oxide.


The risk or severity of adverse effects can be increased when fludrocortisone is combined with norfloxacin.


The risk or severity of adverse effects can be increased when oxaprozin is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when CALCIUM CHLORIDE is combined with Calcium acetate.


The risk or severity of adverse effects can be increased when prilocaine is combined with etizolam.


The risk or severity of adverse effects can be increased when Arotinolol is combined with floctafenine.


The risk or severity of adverse effects can be increased when imipramine is combined with propranolol.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with Pimecrolimus.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Difenoxin.


The risk or severity of adverse effects can be increased when bromocriptine is combined with histamine.


The risk or severity of adverse effects can be increased when Tianeptine is combined with PIRBUTEROL.


The risk or severity of adverse effects can be increased when nimesulide is combined with fluocinonide.


The risk or severity of adverse effects can be increased when mesoridazine is combined with baclofen.


The risk or severity of adverse effects can be increased when codeine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with indapamide.


The risk or severity of adverse effects can be increased when QUINETHAZONE is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when tiapride is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when butorphanol is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when losartan is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when Olmesartan is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when Fesoterodine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with flumethasone.


The risk or severity of adverse effects can be increased when trazodone is combined with flunarizine.


The risk or severity of adverse effects can be increased when trazodone is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when fenbufen is combined with alclometasone.


The risk or severity of adverse effects can be increased when trapidil is combined with mesalamine.


The risk or severity of adverse effects can be increased when Etomidate is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with tubocurarine.


The risk or severity of adverse effects can be increased when tiapride is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when metoclopramide is combined with prochlorperazine.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with oxymorphone.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with brotizolam.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with doxepin.


The risk or severity of adverse effects can be increased when triamterene is combined with fosinopril.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with Toloxatone.


The risk or severity of adverse effects can be increased when salicylamide is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with suprofen.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with rasagiline.


The risk or severity of adverse effects can be increased when lisinopril is combined with cilazapril.


The risk or severity of adverse effects can be increased when Articaine is combined with dantrolene.


The risk or severity of adverse effects can be increased when pramipexole is combined with triamterene.


The risk or severity of adverse effects can be increased when cabergoline is combined with diethylstilbestrol.


The risk or severity of adverse effects can be increased when moclobemide is combined with linezolid.


The risk or severity of adverse effects can be increased when buspirone is combined with quazepam.


The risk or severity of adverse effects can be increased when procaine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when proparacaine is combined with sertraline.


The risk or severity of adverse effects can be increased when mesoridazine is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with clopidogrel.


The risk or severity of adverse effects can be increased when mesoridazine is combined with prazepam.


The risk or severity of adverse effects can be increased when ethanol is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Sapropterin is combined with levodopa.


The risk or severity of adverse effects can be increased when ramipril is combined with reserpine.


The risk or severity of adverse effects can be increased when chlormezanone is combined with clemastine.


The risk or severity of adverse effects can be increased when Salsalate is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with lisinopril.


The risk or severity of adverse effects can be increased when betaxolol is combined with propranolol.


The risk or severity of adverse effects can be increased when imipramine is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when Bortezomib is combined with Nebivolol.


The risk or severity of adverse effects can be increased when Eprosartan is combined with tenoxicam.


The risk or severity of adverse effects can be increased when Halazepam is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with scopolamine.


The risk or severity of adverse effects can be increased when hydrocortisone is combined with malathion.


The risk or severity of adverse effects can be increased when Olsalazine is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when protriptyline is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when protriptyline is combined with Escitalopram.


The risk or severity of adverse effects can be increased when ondansetron is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when Mometasone is combined with galanthamine.


The risk or severity of adverse effects can be increased when Mometasone is combined with Isoflurophate.


The risk or severity of adverse effects can be increased when carprofen is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with equilin.


The risk or severity of adverse effects can be increased when cilnidipine is combined with papaverine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when cilnidipine is combined with nifedipine.


The risk or severity of adverse effects can be increased when docetaxel is combined with diethylstilbestrol.


The risk or severity of adverse effects can be increased when bromazepam is combined with olanzapine.


The risk or severity of adverse effects can be increased when dibucaine is combined with clidinium.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Etidocaine.


The risk or severity of adverse effects can be increased when salicylic acid is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with pyridostigmine.


The risk or severity of adverse effects can be increased when pentazocine is combined with Normethadone.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with difluprednate.


The risk or severity of adverse effects can be increased when Nabilone is combined with tretinoin.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with halcinonide.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Asenapine.


The risk or severity of adverse effects can be increased when tolnaftate is combined with Lacidipine.


The risk or severity of adverse effects can be increased when Icatibant is combined with flunisolide.


The risk or severity of adverse effects can be increased when dichlorphenamide is combined with hydralazine.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Olmesartan.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with Flibanserin.


The risk or severity of adverse effects can be increased when bupivacaine is combined with topiramate.


The risk or severity of adverse effects can be increased when etizolam is combined with Pizotifen.


The risk or severity of adverse effects can be increased when fenoldopam is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when Pipamperone is combined with methazolamide.


The risk or severity of adverse effects can be increased when Pipamperone is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when dexamethasone is combined with decamethonium.


The risk or severity of adverse effects can be increased when Olmesartan is combined with Spirapril.


The risk or severity of adverse effects can be increased when thiothixene is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when Pipamperone is combined with tiagabine.


The risk or severity of adverse effects can be increased when Pipamperone is combined with zonisamide.


The risk or severity of adverse effects can be increased when halothane is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with Perospirone.


The risk or severity of adverse effects can be increased when Olmesartan is combined with cilazapril.


The risk or severity of adverse effects can be increased when olanzapine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with Methylscopolamine bromide.


The risk or severity of adverse effects can be increased when Butethal is combined with efavirenz.


The risk or severity of adverse effects can be increased when pentobarbital is combined with baclofen.


The risk or severity of adverse effects can be increased when butorphanol is combined with nalbuphine.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when butorphanol is combined with oxazepam.


The risk or severity of adverse effects can be increased when tolterodine is combined with morphine.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Salmeterol.


The risk or severity of adverse effects can be increased when floctafenine is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when fludiazepam is combined with fexofenadine.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when floctafenine is combined with amcinonide.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with maprotiline.


The risk or severity of adverse effects can be increased when Asenapine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when thioridazine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when oxycodone is combined with Remoxipride.


The risk or severity of adverse effects can be increased when Bivalirudin is combined with Deferasirox.


The risk or severity of adverse effects can be increased when oxycodone is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when Naftifine is combined with diltiazem.


The risk or severity of adverse effects can be increased when ramipril is combined with azelastine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when ramipril is combined with dipyridamole.


The risk or severity of adverse effects can be increased when clidinium is combined with tiagabine.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with thiamylal.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with Olmesartan.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when quetiapine is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with resveratrol.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with promethazine.


The risk or severity of adverse effects can be increased when Tolcapone is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when clorazepate is combined with mepivacaine.


The risk or severity of adverse effects can be increased when gabapentin is combined with dantrolene.


The risk or severity of adverse effects can be increased when niflumic acid is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when cilnidipine is combined with simvastatin.


The risk or severity of adverse effects can be increased when mepivacaine is combined with protriptyline.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with carvedilol.


The risk or severity of adverse effects can be increased when mepivacaine is combined with cetirizine.


The risk or severity of adverse effects can be increased when oxprenolol is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Tolcapone is combined with Riociguat.


The risk or severity of adverse effects can be increased when alclofenac is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when etodolac is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Olopatadine is combined with acemetacin.


The risk or severity of adverse effects can be increased when fosinopril is combined with Masoprocol.


The risk or severity of adverse effects can be increased when bromazepam is combined with proparacaine.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with zotepine.